Neuphoria Therapeutics Inc. (NEUP) quarterly balance sheet — complete assets, liabilities & equity history
Neuphoria Therapeutics Inc. (NEUP) balance sheet — 27-year assets, liabilities & shareholders' equity history
| Metric | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|
| Total Current Assets | 21.07M | 21.66M | 23.39M | 13.95M | 22.85M | 17.09M | 4.4M | 8.43M | 13.19M | 0 | 16.86M | 8.43M |
| Cash & Short-Term Investments | 19.87M | 19.44M | 22.17M | 13.65M | 21.59M | 17.05M | 4.34M | 8.08M | 12.61M | 0 | 14.87M | 8.08M |
| Cash Only | 19.87M | 19.44M | 22.17M | 13.65M | 21.59M | 17.05M | 4.34M | 8.08M | 12.61M | 0 | 14.87M | 8.08M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 813.43K | 1.61M | 1.11M | 1.76K | 0 | 24.59K | 35.56K | 115.96K | 126.88K | 0 | 0 | 115.96K |
| Days Sales Outstanding | 93.73 | - | - | - | - | 0.11 | 6.51 | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 611.91K | 66.22K | 78.56K | 136.58K | -489 | -30 | -68 | 351 | 0 | 621.12K | 0 |
| Total Non-Current Assets | 7.64M | 13.15M | 13.21M | 13.39M | 20.59M | 13.62M | 13.77M | 14.49M | 14.46M | 0 | 22M | 14.49M |
| Property, Plant & Equipment | 0 | 0 | 0 | 77.79K | 160.12K | 126.84K | 152.2K | 199.41K | 218.97K | 0 | 416.18K | 199.41K |
| Fixed Asset Turnover | - | - | - | - | -72.99x | 179.56x | 6.09x | - | - | - | - | - |
| Goodwill | 3.5M | 8.84M | 8.74M | 8.67M | 13.13M | 8.45M | 8.41M | 8.9M | 8.69M | 0 | 12.95M | 8.9M |
| Intangible Assets | 4.14M | 4.31M | 4.47M | 4.64M | 7.3M | 4.97M | 5.14M | 5.3M | 5.47M | 0 | 8.51M | 5.3M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 74.73K | 73.98K | 82.49K | 78.83K | 0 | 0 | 82.49K |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | -568 | 816 | 98 | -795 | 0 | 119.02K | 0 |
| Total Assets | 28.71M | 34.81M | 36.6M | 27.34M | 43.44M | 30.71M | 18.17M | 22.92M | 27.65M | 0 | 38.86M | 22.92M |
| Asset Turnover | 0.04x | - | - | - | -0.28x | 1.02x | 0.05x | - | - | - | - | - |
| Asset Growth % | -33.91% | 13.34% | 101.44% | 19.32% | 57.11% | - | -53.24% | -0% | - | - | - | - |
| Total Current Liabilities | 756.58K | 1.51M | 2.59M | 5.12M | 6.41M | 1.55M | 2.13M | 2.55M | 3.83M | 0 | 4.42M | 2.55M |
| Accounts Payable | 385.58K | 627.18K | 780.07K | 1.37M | 1.75M | 745.34K | 1.53M | 1.33M | 2.24M | 0 | 2.56M | 1.33M |
| Days Payables Outstanding | 278.13 | 382.19 | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 34.34K | 34.23K | 50.13K | 33.01K | 49.76K | 31.4K | 31.09K | 34.66K | 33.12K | 0 | 1.12M | 164.54K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 314.76K | 851.9K | 1.76M | 32.7K | 54.33K | 255.87K | 31.59K | 112.24K | 328.89K | 0 | 1 | 341.94K |
| Current Ratio | 27.85x | 14.31x | 9.04x | 2.72x | 3.56x | 11.01x | 2.06x | 3.30x | 3.45x | - | 3.81x | 3.30x |
| Quick Ratio | 27.85x | 14.31x | 9.04x | 2.72x | 3.56x | 11.01x | 2.06x | 3.30x | 3.45x | - | 3.81x | 3.30x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 3.35M | 3.87M | 4.31M | 9.71M | 8.15M | 3.16M | 2.29M | 3.29M | 6.33M | 0 | 5.4M | 3.3M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 19.32K | 49.82K | 89.47K | 117.63K | 0 | 272.18K | 89.47K |
| Deferred Tax Liabilities | 355.94K | 390.73K | 425.53K | 460.32K | 0 | 761.74K | 842.92K | 831.32K | 963.54K | 0 | 0 | 831.32K |
| Other Non-Current Liabilities | 3M | 3.48M | 3.89M | 9.25M | 8.15M | 2.38M | 1.39M | 2.37M | 5.25M | 0 | 5.12M | 2.37M |
| Total Liabilities | 4.11M | 5.39M | 6.9M | 14.83M | 14.57M | 4.72M | 4.42M | 5.85M | 10.16M | 0 | 9.82M | 5.85M |
| Total Debt | 34.34K | 34.23K | 50.13K | 118.22K | 226.49K | 172.46K | 199.4K | 254.01K | 272.74K | 0 | 1.57M | 254.01K |
| Net Debt | -19.83M | -19.41M | -22.12M | -13.53M | -21.37M | -16.87M | -4.14M | -7.83M | -12.37M | 0 | -13.3M | -7.83M |
| Debt / Equity | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.02x | - | 0.05x | 0.01x |
| Debt / EBITDA | 19.43x | - | - | - | - | 0.01x | - | - | - | - | - | - |
| Net Debt / EBITDA | -11216.73x | - | - | - | - | -0.83x | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 24.6M | 29.42M | 29.7M | 12.51M | 28.87M | 26M | 13.75M | 17.07M | 17.49M | 0 | 29.04M | 17.07M |
| Equity Growth % | -14.8% | 13.18% | 116.04% | -26.71% | 65.08% | - | -52.65% | -0% | - | - | - | - |
| Book Value per Share | 4.55 | 5.44 | 6.55 | 5.57 | 17.79 | 0.11 | 0.06 | 0.07 | 0.19 | - | 0.21 | 0.14 |
| Total Shareholders' Equity | 24.6M | 29.42M | 29.7M | 12.51M | 28.87M | 26M | 13.75M | 17.07M | 17.49M | 0 | 29.04M | 17.07M |
| Common Stock | 54 | 54 | 54 | 23 | 29 | 19 | 16 | 0 | 11 | 0 | 233.86M | 0 |
| Retained Earnings | -191.8M | -186.89M | -186.39M | -188.25M | -270.98M | -169.46M | -180.72M | -178.78M | -177.98M | 0 | -218.66M | -178.78M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -2.06M | -2.07M | -2.23M | -2.8M | -4.32M | -3.91M | -3.72M | -2.43M | -3.01M | 0 | 13.84M | -2.43M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |